Dimethyl-[3-(2-methylprop-2-enoylamino)propyl]-(oxiran-2-ylmethyl)azanium chloride
C12H23ClN2O2 — CID 87225552
Data last refreshed: (MolForge compound catalog, from PubChem)
About Dimethyl-[3-(2-methylprop-2-enoylamino)propyl]-(oxiran-2-ylmethyl)azanium chloride
Dimethyl-[3-(2-methylprop-2-enoylamino)propyl]-(oxiran-2-ylmethyl)azanium chloride (PubChem CID 87225552) has the molecular formula C12H23ClN2O2 and a molecular weight of 262.78 g/mol. Its IUPAC name is dimethyl-[3-(2-methylprop-2-enoylamino)propyl]-(oxiran-2-ylmethyl)azanium chloride.
Molecular Properties
| Compound Name | Dimethyl-[3-(2-methylprop-2-enoylamino)propyl]-(oxiran-2-ylmethyl)azanium chloride |
|---|---|
| PubChem CID | 87225552 |
| Molecular Formula | C12H23ClN2O2 |
| Molecular Weight | 262.78 g/mol |
| Exact Mass | 262.14 |
| IUPAC Name | dimethyl-[3-(2-methylprop-2-enoylamino)propyl]-(oxiran-2-ylmethyl)azanium chloride |
| SMILES | C=C(C)C(=O)NCCC[N+](C)(C)CC1CO1.[Cl-] |
| InChI | InChI=1S/C12H22N2O2.ClH/c1-10(2)12(15)13-6-5-7-14(3,4)8-11-9-16-11;/h11H,1,5-9H2,2-4H3;1H |
| InChIKey | JRJQESKYCRXOMX-UHFFFAOYSA-N |
| XLogP | -2.45 |
| TPSA | 41.63 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 17 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 262.78 |
| LogP ≤ 5 | -2.45 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 87225552 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.